Exact Mass: 308.14802355800003
Exact Mass Matches: 308.14802355800003
Found 500 metabolites which its exact mass value is equals to given mass value 308.14802355800003,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Phenylbutazone
A drug that has anti-inflammatory, antipyretic, and analgesic activities. It is especially effective in the treatment of ankylosing spondylitis. It also is useful in rheumatoid arthritis and Reiter's syndrome (investigational indication). Although phenylbutazone is effective in gouty arthritis, risk/benefit considerations indicate that this drug should not be employed for this disease. (From AMA Drug Evaluations Annual, 1994, p1822) M - Musculo-skeletal system > M02 - Topical products for joint and muscular pain > M02A - Topical products for joint and muscular pain > M02AA - Antiinflammatory preparations, non-steroids for topical use M - Musculo-skeletal system > M01 - Antiinflammatory and antirheumatic products > M01A - Antiinflammatory and antirheumatic products, non-steroids > M01AA - Butylpyrazolidines C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics CONFIDENCE standard compound; EAWAG_UCHEM_ID 3615 EAWAG_UCHEM_ID 3615; CONFIDENCE standard compound CONFIDENCE standard compound; INTERNAL_ID 1158 D000893 - Anti-Inflammatory Agents D018501 - Antirheumatic Agents
Inulicin
Britannilactone 1-O-acetate is a natural product found in Pentanema britannicum and Inula japonica with data available. Inulicin (1-O-Acetylbritannilactone) is an active compound that inhibits VEGF-mediated activation of Src and FAK. Inulicin (1-O-Acetylbritannilactone) inhibits LPS-induced PGE2 production and COX-2 expression, and NF-κB activation and translocation. Inulicin (1-O-Acetylbritannilactone) is an active compound that inhibits VEGF-mediated activation of Src and FAK. Inulicin (1-O-Acetylbritannilactone) inhibits LPS-induced PGE2 production and COX-2 expression, and NF-κB activation and translocation.
DMXB-A
D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018679 - Cholinergic Agonists
15-Deacetylcalonectrin
15-Deacetylcalonectrin is a metabolite of Calonectria nivali
ACRL Toxin II
ACRL Toxin II is found in citrus. ACRL Toxin II is produced by the fungus Alternaria citri on rough lemo Production by the fungus Alternaria citri on rough lemon. ACRL Toxin II is found in citrus.
Dihydrocumambrin A
Dihydrocumambrin A is found in garland chrysanthemum. Dihydrocumambrin A is from Chrysanthemum coronarium (chop-suey greens). From Chrysanthemum coronarium (chop-suey greens). Dihydrocumambrin A is found in garland chrysanthemum and herbs and spices.
Fructosyllysine
1-[(5-Amino-5-carboxypentyl)amino]-1-deoxyfructose is found in milk and milk products. Amadori rearrangement produced found in heated milk and other foodstuff Amadori rearrangement production found in heated milk and other foodstuffs Fructosyl-lysine (Fructoselysine) is an amadori glycation product from the reaction of glucose and lysine by the Maillard reaction. Fructosyl-lysine is the precursor to glucosepane, a lysine–arginine protein cross-link that can be an indicator in diabetes?detection[1].
2-Carboxy-1-[5-(2-carboxy-1-pyrrolidinyl)-2-hydroxy-2,4-pentadienylidene]pyrrolidinium
2-Carboxy-1-[5-(2-carboxy-1-pyrrolidinyl)-2-hydroxy-2,4-pentadienylidene]pyrrolidinium is a maillard product from reaction of L-proline and 2-Furancarboxaldehyde
1-Deoxy-1-(N6-lysino)-D-fructose
1-Deoxy-1-(N6-lysino)-D-fructose is a very strong basic compound (based on its pKa).
(2R)-2-Amino-6-[[(3S,4R,5R)-3,4,5,6-tetrahydroxy-2-oxohexyl]amino]hexanoic acid
1-O-Acetyl britannilactone
Inulicin (1-O-Acetylbritannilactone) is an active compound that inhibits VEGF-mediated activation of Src and FAK. Inulicin (1-O-Acetylbritannilactone) inhibits LPS-induced PGE2 production and COX-2 expression, and NF-κB activation and translocation. Inulicin (1-O-Acetylbritannilactone) is an active compound that inhibits VEGF-mediated activation of Src and FAK. Inulicin (1-O-Acetylbritannilactone) inhibits LPS-induced PGE2 production and COX-2 expression, and NF-κB activation and translocation.
2-((2-(Dimethylamino)ethyl)thio)-3-phenylquinoline
C19H20N2S (308.13471200000004)
4-Butyl-5-hydroxy-1,2-diphenylpyrazol-3-one
3-(2,4-Dimethoxybenzylidene)anabaseine
2-(4-Amino-1-isopropyl-1H-pyrazolo[3,4-d]pyrimidin-3-yl)-1H-indol-5-ol
C16H16N6O (308.13855259999997)
Dihydro-beta-cyclopyrethrosin
4beta-Acetoxy-6alpha-hydroxy-11(13)-pseudoguaien-12,8alpha-olide
Torrentin
Nematolin
nitrosin
6alpha-Acetoxy-4beta-hydroxy-11(13)-pseudoguaien-12,8alpha-olide
2,4-Dihydroxy-3-(1,1-dimethyl-2-propenyl)chalcone
1-Acetylerivanin|1alpha-acetoxy-3alpha-hydroxy-5,7alpha,6,11beta(H)-eudesm-4,15-en-6,12-olide
1alpha-acetoxy-4alpha-hydroxy-5,7alpha,6,11beta(H)-eudesm-2,3-en-6,12-olide|1alpha-Acetoxy-4alpha-hydroxy-5alpha,6beta,7alpha,11beta-H-eudesm-2-en-12,6-olide
8-Ac-(1beta,6alpha,8beta,11alphaH)-1,8-Dihydroxy-3-eudesmen-12,6-olide
1-(2,2-dimethyl-3-hydroxypropyl)-2-isobutyl phthalate
1alpha-acetoxy-5beta-hydroxyeudesm-3-en-6beta,11betaH-12,6-olide
NAPHTHO(1,8-bc)PYRAN-7,8-DIONE, 6,9-DIMETHYL-3-(4-METHYL-3-PENTENYL)-
3,4,5-Tri-Me ether,O-(3-methylbutanoyl)-3-(3,4,5-Trihydroxyphenyl)-2-propen-1-ol|3,4,5-trimethoxycinnamyl isovalerate
8beta-Acetoxy-3beta-hydroxy-11alpha,13-dihydrocostunolid
8-Hydroxy-3,8a-dimethyl-5-methylene-2-oxododecahydronaphtho[2,3-b]furan-4-yl acetate #
(4S,4aR,5S,8aR,9aS)-4-(acetyloxy)-4a,5,6,7,8,8a,9,9a-octahydro-9a-hydroxy-3,4a,5-trimethylnaphtho[2,3-b]furan-2(4H)-one|(6beta,8alpha)-6-(acetyloxy)-8-hydroxyeremophil-7(11)-en-12,8-olide
4-Ac-4,5-Seconeopulchell-5-ene|4-O-acetyl-4,5-seco-neopulchell-5-ene
(2-Methyl-2-propyl-propan-1,3-diol)-D(?)-glucuronid|<2-Methyl-2-propyl-propan-1,3-diol>-D(?)-glucuronid
Asnipyrone B
A member of the class of 2-pyranones that is 2H-pyran-2-one substituted by a methoxy group at position 4 and a 3,5-dimethyl-6-phenylhexa-1,3,5-trien-1-yl group at position 6 (the 1E,3E,5E stereoisomer). It has been isolated from an endophytic fungus Aspergillus niger.
4-acetoxy-1beta,5beta-epoxy-10alphaH-xantha-11(13)-en-12,8beta-olide|4-Acetoxy-1??,5??-epoxy-10??H-xantha-11(13)-en-12,8??-olide
1beta,6alpha,8beta-Trihydroxy-11,13-dihydroeudesm-4-en-6-olide 8-acetate
4-Methylbenzenesulfonyl-3,3-Dimethylbicyclo[2.2.1]heptane-2-methanol
C17H24O3S (308.14460740000004)
9beta-acetoxy-15-hydroxyeudesm-4,11(13)-dien-12-oic acid
2,2-Dimethyl-5,6,8-trimethoxy-7-(1-methoxyethyl)-2H-1-benzopyran
3alpha-acetoxy-11alphaH,13-dihydrodamsin|hydroxydihydrodamsin
Ac-(1alpha,3beta,4Z,8beta,10beta,11alpha)-1,10-Epoxy-3-hydroxy-4-germacren-12,8-olide
methyl (3S,5S)-5-hydroxy-3-(beta-D-glucopyranosyl)-hexanoate
2alpha-acetoxy-5alpha-hydroxy-11alphaH-eudesma-4(15)-en-12,8beta-olide
4beta,5beta-epoxy-9beta-acetoxyeudesm-11(13)-en-12-oic acid
(1R*,4R*,5R*)-5-hydroxy-4-[(E)-7-hydroxy-4-methylhept-3-enyl]-4,8-dimethyl-3-oxabicyclo[3.3.0]octan-7-en-2,6-dione|gomadalactone B
(3R),(4S)-4-hydroxylasiodiplodin|(3R,4S)-4-hydoxylasiodiplodin
1beta-acetoxy-7-drimen-11alpha-ol-12,11-lactone|1??-Acetoxy-7-drimen-11??-ol-12,11-lactone
Multiorthoquinone
A diterpenoid that is phenanthrene-3,4-dione substituted by a methoxy group at position 6, a methyl groups at positions 7 and 8 and an isopropyl group at position 2. A norabietane derivative, it is isolated from Salvia multicaulis and exhibits antitubercular activity.
(1S,4S,5S,6S,7S,10R)-1-hydroxy-15-acetoxyeudesm-11(13)-en-6,12-olide
1alpha-acetoxy-3beta-hydroxyeudesm-4-en-6beta,11betaH-12,6-olide
6alpha-acetoxy-1-hydroxy-4alphaH-1,10-secoeudesma-5(10),11(13)-dien-12,8beta-olide
11alpha,13-dihydro-2-O-acetylflorilenalin|11alphaH,13dihydroflorilenalin acetate|2alpha-acetoxy-4alpha-hydroxy-1beta,5alpha,11alphaH-guai-10(14)-en-12,8beta-olide
2-Ac-4,5-Seconeopulchell-5-ene|4,5-seco-neopulchell-5-ene-2-O-acetate
(1S,2R,5R,6S,7S,8S,10R)-6-hydroxy-2-ethoxy-4-oxopseudoguai-11(13)-en-12,8-olide
A pseudoguaianolide with anti-inflammatory activity isolated from the aerial parts of Inula hupehensis.
15-hydroxyajanolide A|3beta-acetoxy-15-hydroxygermacra-1(10)E,4Z-dien-6beta,7alpha,11alphaH-12,6-olide|zawadskinolide B
18-hydroxy nor fluorocurarine|18-Hydroxynorfluorocurarine|strychnofluorine (18-hydroxynorfluorocurarine)
(20alpha)-20-methyl-15,16-didehydro-18-oxayohimban-21-one|Latifoliamide C
3beta-acetoxy-5alpha-angeloyloxy-7-deoxycarvotacetone|vernonione
2beta-acetoxy-4alpha-hydroxy-11beta,13-dihydroburkeolide
9-Ac-(5alpha,9??)-5,9-Dihydroxy-4(15),11(13)-eudesmadien-12-oic acid|9beta-Acetoxy-5alpha-hydroxycostic Acid
7,8-seco-2,3,5-trihydroxy-12-acetoxycalam-8-ene|myrracalamene B
4-methoxymagnaldehyde B|5-allyl-2-hydroxyphenyl-4-methoxy-3-cinnamic aldehyde
10betaH,11alphaH-7alpha-acetoxy-8-oxoeremophilan-12,6beta-olide|7-O-acetylsubspicatolide
11-hydroxy-1beta-methoxy-8-oxoeremophila-6,9-dien-12-oic acid methyl ester
4-Ac-4, 10-Dihydroxy-11(13)-guaien-12, 8-olide|4alpha-acetoxy-10beta-hydroxy-1beta(H),5alpha(H)-guai-11(13)-en-8alpha,12-olide
4-hydroxy-2,2-dimethyl-pyranoflavan|4-hydroxy-7,8-(2,2-dimethylpyran)flavan
(5Z,6R)-1,6,7,8-tetrahydro-5-(hydroxyethylidene)-7-methylene-2H-3,6-ethanoazonino[5,4-b]indol-4(5H)-one|pericidine
1alpha-hydroxy-4beta-O-acetylpseudoguaian-6beta,12-olide
methyl gamma-methyl-delta-hydroxy-pentanoic acid beta-D-glucopyranoside
5-Allyl-2-(4-methoxyphenyl)-7-methoxy-3-methylbenzofuran
(E)-2-(4-methoxyphenyl)-7-methoxy-3-methyl-5-(prop-1-en-1-yl)benzofuran|eupomatenoid 16|eupomatenoid-16
Alpinoid D
Alpinoid D is a natural product found in Alpinia officinarum with data available.
N-[2-(2,2-Dimethyl-2H-1-benzopyran-6-yl)ethyl]pyridine-3-carboxamide
2,4-dihydroxy-3-(3-methylbut-2-enyl)chalcone|Flemistricin-A|Flemistrictin|Iso-cordoin|Isocordoin
2,4-Dihydroxy-3,6-dimethoxy-5-(3,3-dimethylallyl)-butyrophenon
phenylbutazone
M - Musculo-skeletal system > M02 - Topical products for joint and muscular pain > M02A - Topical products for joint and muscular pain > M02AA - Antiinflammatory preparations, non-steroids for topical use M - Musculo-skeletal system > M01 - Antiinflammatory and antirheumatic products > M01A - Antiinflammatory and antirheumatic products, non-steroids > M01AA - Butylpyrazolidines A member of the class of pyrazolidines that is 1,2-diphenylpyrazolidine-3,5-dione carrying a butyl group at the 4-position. C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents D018501 - Antirheumatic Agents
1H-(Indol-3-yl)-6,7-dimethoxy-1,2,3,4-tetrahydro-isoquinoline
Vincanidine
Origin: Plant; Formula(Parent): C19H20N2O2; Bottle Name:Vincanidine; PRIME Parent Name:Vincanidine; PRIME in-house No.:V0312; SubCategory_DNP: Monoterpenoid indole alkaloids, Aspidosperma alkaloids, Indole alkaloids Annotation level-1
(11S,17S)-12-ethylidene-6-hydroxy-8,14-diazapentacyclo(9.5.2.0(1,9).0(2,7).0(14,17))octadeca-2(7),3,5,9-tetraene-10-carbaldehyde
Origin: Plant; Formula(Parent): C19H20N2O2; Bottle Name:Vincanidine; PRIME Parent Name:Vincanidine; PRIME in-house No.:V0312; SubCategory_DNP: Monoterpenoid indole alkaloids, Aspidosperma alkaloids, Indole alkaloids Formula(Parent): C19H20N2O2; Bottle Name:Vincanidine; Origin: Plant; PRIME Parent Name:Vincanidine; PRIME in-house No.:V0312; SubCategory_DNP: Monoterpenoid indole alkaloids, Aspidosperma alkaloids, Indole alkaloids PRIME in-house No.:V0312; Origin: Plant; Formula(Parent): C19H20N2O2; Bottle Name:Vincanidine; PRIME Parent Name:Vincanidine; SubCategory_DNP: Monoterpenoid indole alkaloids, Aspidosperma alkaloids, Indole alkaloids
Fructoselysine
A glyco-amino acid consisting of a D-fructosyl residue attached to the epsilon-amino group of L-lysine.
UK-156819
CONFIDENCE standard compound; INTERNAL_ID 836; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4744; ORIGINAL_PRECURSOR_SCAN_NO 4743 CONFIDENCE standard compound; INTERNAL_ID 836; DATASET 20200303_ENTACT_RP_MIX500; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3450; ORIGINAL_PRECURSOR_SCAN_NO 3448 CONFIDENCE standard compound; INTERNAL_ID 836; DATASET 20200303_ENTACT_RP_MIX500; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3446; ORIGINAL_PRECURSOR_SCAN_NO 3443 CONFIDENCE standard compound; INTERNAL_ID 836; DATASET 20200303_ENTACT_RP_MIX500; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3439; ORIGINAL_PRECURSOR_SCAN_NO 3437 CONFIDENCE standard compound; INTERNAL_ID 836; DATASET 20200303_ENTACT_RP_MIX500; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3452; ORIGINAL_PRECURSOR_SCAN_NO 3448 CONFIDENCE standard compound; INTERNAL_ID 836; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4773; ORIGINAL_PRECURSOR_SCAN_NO 4772 CONFIDENCE standard compound; INTERNAL_ID 836; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7655; ORIGINAL_PRECURSOR_SCAN_NO 7653 CONFIDENCE standard compound; INTERNAL_ID 836; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7663; ORIGINAL_PRECURSOR_SCAN_NO 7661 CONFIDENCE standard compound; INTERNAL_ID 836; DATASET 20200303_ENTACT_RP_MIX500; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7644; ORIGINAL_PRECURSOR_SCAN_NO 7642 CONFIDENCE standard compound; INTERNAL_ID 836; DATASET 20200303_ENTACT_RP_MIX500; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7660; ORIGINAL_PRECURSOR_SCAN_NO 7658 CONFIDENCE standard compound; INTERNAL_ID 836; DATASET 20200303_ENTACT_RP_MIX500; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7675; ORIGINAL_PRECURSOR_SCAN_NO 7673 CONFIDENCE standard compound; INTERNAL_ID 836; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7714; ORIGINAL_PRECURSOR_SCAN_NO 7712
8-(3-Methoxy-2-(methoxycarbonyl)phenyl)octanoic acid
Fructosyllysine
Fructosyl-lysine (Fructoselysine) is an amadori glycation product from the reaction of glucose and lysine by the Maillard reaction. Fructosyl-lysine is the precursor to glucosepane, a lysine–arginine protein cross-link that can be an indicator in diabetes?detection[1].
5-(2-Carboxy-1-pyrrolidinyl)-2-hydroxy-2,4-pentadienal (2-carboxypyrrolidine)imine
15-Decalonectrin
Dihydrocumambrin A
15-Acetoxyscirpenol
Mycotoxin from Fusarium roseum and Fusarium sulphureum
4-(PHENYLCARBONYL)PHENYLBORONIC ACID, PINACOL ESTER
1,3-diisocyanato-2-methylbenzene,3-(3-hydroxypropoxy)propan-1-ol
furan-2,5-dione,3-(3-hydroxypropoxy)propan-1-ol,propane-1,2-diol
(E)-2-(4-METHOXY-3-(3-METHOXYPROPOXY)BENZYLIDENE)-3-METHYLBUTANOIC ACID
ethyl 2-[4-(3-amino-4-nitrophenyl)piperazin-1-yl]acetate
C14H20N4O4 (308.14844800000003)
(S)-tert-Butyl 3-(2-nitrophenoxy)pyrrolidine-1-carboxylate
tert-Butyl 4-(5-nitropyridin-2-yl)piperazine-1-carboxylate
C14H20N4O4 (308.14844800000003)
diethyl 2-acetamido-2-(pyridin-4-ylmethyl)propanedioate
tert-Butyl 4-(3-nitro-2-pyridyl)piperazine-1-carboxylate
C14H20N4O4 (308.14844800000003)
5-CHLORO-1-TRIISOPROPYLSILANYL-1H-PYRROLO[2,3-B]PYRIDINE
2-(3-CHLORO-5-(CYCLOPROPYLMETHOXY)PHENYL)-4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLANE
C16H22BClO3 (308.13504420000004)
1H-Pyrrolo[2,3-b]pyridine, 4-chloro-1-[tris(1-methylethyl)silyl]-
(6aR)-1,2,3,8,9-pentadeuterio-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol,hydrochloride
C17H13ClD5NO2 (308.13398569000003)
1H-Pyrrolo[2,3-b]pyridine, 6-chloro-1-[tris(1-methylethyl)silyl]
2-trans-benzoyl-5-trans-phenyl-1-cyclohexanecarboxylic acid
3-(2-MALEIMIDOETHYLCARBAMOYL)-2,2,5,5-TETRAMETHYL-1-PYRROLIDINYLOXY
1,3-diisocyanato-2-methylbenzene,2-ethyl-2-(hydroxymethyl)propane-1,3-diol
tert-Butyl 4-(2-fluoro-6-formylphenyl)piperazine-1-carboxylate
PP242
C16H16N6O (308.13855259999997)
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C61074 - Serine/Threonine Kinase Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C2201 - mTOR Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor Torkinib (PP 242) is a selective and ATP-competitive mTOR inhibitor with an IC50 of 8 nM[1]. PP242 inhibits both mTORC1 and mTORC2 with IC50s of 30 nM and 58 nM, respectively[2]. Torkinib (PP 242) is a selective and ATP-competitive mTOR inhibitor with an IC50 of 8 nM[1]. PP242 inhibits both mTORC1 and mTORC2 with IC50s of 30 nM and 58 nM, respectively[2].
(3S)-3-tert-butoxycarbonylamino-1-nitro-2-oxo-4-phenylbutane
TERT-BUTYL 3-(2-NITROPHENOXY)PYRROLIDINE-1-CARBOXYLATE
(4-((2-((tert-Butoxycarbonyl)amino)ethyl)carbamoyl)phenyl)boronic acid
3-chloro-6-[4-(piperidin-1-ylcarbonyl)piperidin-1-yl]pyridazine
4-(6-Nitro-3-pyridinyl)-1-piperazinecarboxylic acid tert-butyl ester
C14H20N4O4 (308.14844800000003)
2-((2-(Dimethylamino)ethyl)thio)-3-phenylquinoline
C19H20N2S (308.13471200000004)
D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists
2-Amino-6-[(3,4,5,6-tetrahydroxy-2-oxohexyl)amino]hexanoic acid (non-preferred name)
N-[2-(5-methoxy-2-phenyl-1H-indol-3-yl)ethyl]acetamide
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones
Nigerapyrone F
A member of the class of 2-pyranones that is 2H-pyran-2-one substituted by a methoxy group at position 4 and a 3,5-dimethyl-6-phenylhexa-1,3,5-trien-1-yl group at position 6 (the 1E,3E,5Z stereoisomer). It has been isolated from an endophytic fungus Aspergillus niger.
Nigerapyrone H
A member of the class of 2-pyranones that is 2H-pyran-2-one substituted by a methoxy group at position 4 and a 3,5-dimethyl-6-phenylhexa-1,3,5-trien-1-yl group at position 6 (the 1Z,3E,5E stereoisomer). It has been isolated from an endophytic fungus Aspergillus niger.
Nigerapyrone G
A member of the class of 2-pyranones that is 2H-pyran-2-one substituted by a methoxy group at position 4 and a 3,5-dimethyl-6-phenylhexa-1,3,5-trien-1-yl group at position 6 (the 1E,3Z,5E stereoisomer). It has been isolated from an endophytic fungus Aspergillus niger.
3-[(2,5-dimethylanilino)methyl]-6-methoxy-1H-quinolin-2-one
2,5-Diaziridinyl-3,6-bis(2-hydroxyethylamino)-1,4-benzoquinone
C14H20N4O4 (308.14844800000003)
33627-41-7
Inulicin (1-O-Acetylbritannilactone) is an active compound that inhibits VEGF-mediated activation of Src and FAK. Inulicin (1-O-Acetylbritannilactone) inhibits LPS-induced PGE2 production and COX-2 expression, and NF-κB activation and translocation. Inulicin (1-O-Acetylbritannilactone) is an active compound that inhibits VEGF-mediated activation of Src and FAK. Inulicin (1-O-Acetylbritannilactone) inhibits LPS-induced PGE2 production and COX-2 expression, and NF-κB activation and translocation.
12-Ethylidene-6-hydroxy-8,14-diazapentacyclo[9.5.2.01,9.02,7.014,17]octadeca-2(7),3,5,9-tetraene-10-carbaldehyde
2-Amino-6-[3-(3,4-dihydroxyphenyl)prop-2-enoylamino]hexanoic acid
(1R,11S,12E,17S)-12-ethylidene-6-hydroxy-8,14-diazapentacyclo[9.5.2.01,9.02,7.014,17]octadeca-2(7),3,5,9-tetraene-10-carbaldehyde
fructosyl-lysine
Fructosyl-lysine (Fructoselysine) is an amadori glycation product from the reaction of glucose and lysine by the Maillard reaction. Fructosyl-lysine is the precursor to glucosepane, a lysine–arginine protein cross-link that can be an indicator in diabetes?detection[1].
[(1R,2R,10R)-2-(hydroxymethyl)-1,5-dimethylspiro[8-oxatricyclo[7.2.1.02,7]dodec-5-ene-12,2-oxirane]-10-yl] acetate
2-[2-(3-Ethylphenoxy)ethyl]propanedioic acid diethyl ester
1-O-acetyl-4R,6S-britannilactone
A sesquiterpene lactone that is (3aS,4R,7aR)-3a,4,7,7a-tetrahydro-1-benzofuran-2(3H)-one with a methylidene at position C-3, a hydroxy at C-4, a methyl at C-6, and a (2S)-5-(acetyloxy)pentan-2-yl group at position C-5. A natural product found in Inula britannica var chinensis and Inula japonica.
2-[(2R,5R,6S)-5-[[anilino(oxo)methyl]amino]-6-(hydroxymethyl)-2-oxanyl]acetic acid
2-[(2R,5R,6R)-5-[[anilino(oxo)methyl]amino]-6-(hydroxymethyl)-2-oxanyl]acetic acid
2-[(2S,5R,6R)-5-[[anilino(oxo)methyl]amino]-6-(hydroxymethyl)-2-oxanyl]acetic acid
2-[(2S,5R,6S)-5-[[anilino(oxo)methyl]amino]-6-(hydroxymethyl)-2-oxanyl]acetic acid
2-[(2R,5S,6R)-5-[[anilino(oxo)methyl]amino]-6-(hydroxymethyl)-2-oxanyl]acetic acid
2-[(2S,5S,6R)-5-[[anilino(oxo)methyl]amino]-6-(hydroxymethyl)-2-oxanyl]acetic acid
2-[(2S,5S,6S)-5-[[anilino(oxo)methyl]amino]-6-(hydroxymethyl)-2-oxanyl]acetic acid
2-[(2R,5S,6S)-5-[[anilino(oxo)methyl]amino]-6-(hydroxymethyl)-2-oxanyl]acetic acid
3-amino-7-(4-methylpiperazin-1-yl)-9-oxo-9H-imidazo[1,2-a]indole-2-carbonitrile
C16H16N6O (308.13855259999997)
1-(1H-indol-3-yl)-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline
(1R,11R,12E,17S)-12-ethylidene-6-hydroxy-8,14-diazapentacyclo[9.5.2.01,9.02,7.014,17]octadeca-2(7),3,5,9-tetraene-10-carbaldehyde
(12Z)-12-ethylidene-6-hydroxy-8,14-diazapentacyclo[9.5.2.01,9.02,7.014,17]octadeca-2(7),3,5,9-tetraene-10-carbaldehyde
6-Acetoxy-3,4-dihydro-2,5,7,8-tetramethyl-2H-1-benzopyran-2-ethane-1-thiol
C17H24O3S (308.14460740000004)
10-[2-(4-Hydroxyphenyl)ethylamino]-7-aza-2-azoniatricyclo[6.3.1.04,12]dodeca-1(11),2,4(12),7,9-pentaen-11-ol
3-(2,4-Dimethoxybenzylidene)anabaseine
D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018679 - Cholinergic Agonists
3-[(3aS,4R,5R,8aR)-4-hydroxy-5,7-dimethyl-3-methylidene-2-oxo-4,5,8,8a-tetrahydro-3aH-cyclohepta[b]furan-6-yl]propyl acetate
Inulicin (1-O-Acetylbritannilactone) is an active compound that inhibits VEGF-mediated activation of Src and FAK. Inulicin (1-O-Acetylbritannilactone) inhibits LPS-induced PGE2 production and COX-2 expression, and NF-κB activation and translocation. Inulicin (1-O-Acetylbritannilactone) is an active compound that inhibits VEGF-mediated activation of Src and FAK. Inulicin (1-O-Acetylbritannilactone) inhibits LPS-induced PGE2 production and COX-2 expression, and NF-κB activation and translocation.
1-[(5-Amino-5-carboxypentyl)amino]-1-deoxyfructose
2-Carboxy-1-[5-(2-carboxy-1-pyrrolidinyl)-2-hydroxy-2,4-pentadienylidene]pyrrolidinium
psicosyllysine
An L-lysine derivative having a psicosyl group attached to the side-chain amino group.
(3r,3ar,4s,9r,11ar)-9-hydroxy-3,6,10-trimethyl-2-oxo-3h,3ah,4h,5h,8h,9h,11ah-cyclodeca[b]furan-4-yl acetate
(2s,4s)-4-[(3ar,7s,8as)-7-methyl-3-methylidene-2-oxo-3ah,4h,7h,8h,8ah-cyclohepta[b]furan-6-yl]-4-hydroxybutan-2-yl acetate
1-[2,4-dihydroxy-3,6-dimethoxy-5-(3-methylbut-2-en-1-yl)phenyl]butan-1-one
(3s)-7,12-dihydroxy-14-methoxy-3-methyl-3,4,5,6,7,8,9,10-octahydro-2-benzoxacyclododecin-1-one
(3s,3ar,5ar,6s,7s,9as,9bs)-6-hydroxy-3,5a-dimethyl-9-methylidene-2-oxo-octahydro-3h-naphtho[1,2-b]furan-7-yl acetate
(3s,5s)-5,12-dihydroxy-14-methoxy-3-methyl-3,4,5,6,7,8,9,10-octahydro-2-benzoxacyclododecin-1-one
(1r,5as,9r,9as,9br)-1-hydroxy-6,6,9a-trimethyl-3-oxo-1h,5h,5ah,7h,8h,9h,9bh-naphtho[1,2-c]furan-9-yl acetate
[(3s,3as,6s,6as,9as,9br)-3,6-dimethyl-2,9-dioxo-octahydro-3h-azuleno[4,5-b]furan-9a-yl]methyl acetate
(9s,10s,11ar)-9-hydroxy-3,6,10-trimethyl-2-oxo-4h,5h,8h,9h,11h,11ah-cyclodeca[b]furan-10-yl acetate
{9-hydroxy-6-methyl-3-methylidene-2-oxo-octahydro-3ah-azuleno[4,5-b]furan-9a-yl}methyl acetate
4-hydroxy-3,6,10-trimethyl-2-oxo-3h,3ah,4h,7h,8h,11h,11ah-cyclodeca[b]furan-7-yl acetate
6-[(3r,4e,6s,7s,8e)-3,7-dihydroxy-6,8-dimethyldeca-4,8-dien-2-yl]-4-hydroxypyran-2-one
(3as,6s,6as,9s,9as,9br)-6-(hydroxymethyl)-9a-methyl-3-methylidene-2-oxo-octahydro-3ah-azuleno[4,5-b]furan-9-yl acetate
(4br,10ar)-9-hydroxy-7-methoxy-11,11-dimethyl-4bh,10h,10ah-benzo[b]fluoren-5-one
2-[(1s,2r,5s)-2-(acetyloxy)-5-methyl-4-(3-oxobutyl)cyclohept-3-en-1-yl]prop-2-enoic acid
(3s,7e,8r)-7-ethylidene-5-methyl-5,12-diazatetracyclo[9.7.0.0³,⁸.0¹³,¹⁸]octadeca-1(11),13,15,17-tetraene-2,10-dione
(3s,3ar,4s,6r,6ar,9ar,9bs)-6-hydroxy-3,6,9-trimethyl-2-oxo-3h,3ah,4h,5h,6ah,7h,9ah,9bh-azuleno[4,5-b]furan-4-yl acetate
(3r,5r)-5,12-dihydroxy-14-methoxy-3-methyl-3,4,5,6,7,8,9,10-octahydro-2-benzoxacyclododecin-1-one
(4ar,5s,8r,8as,9ar)-9a-hydroxy-3,4a,5-trimethyl-2-oxo-4h,5h,6h,7h,8h,8ah,9h-naphtho[2,3-b]furan-8-yl acetate
6-[(2r,3s,4e,6s,7r,8e)-3,7-dihydroxy-6,8-dimethyldeca-4,8-dien-2-yl]-4-hydroxypyran-2-one
{2-[2-(tert-butoxy)-5-methoxy-4-methylphenyl]oxiran-2-yl}methyl acetate
[2-(hydroxymethyl)-3-methoxy-4-methyl-5-[(3-methylbut-2-en-1-yl)oxy]phenyl]methyl acetate
8-hydroxy-5,5,8-trimethyl-10-oxo-11-oxatetracyclo[7.3.1.0¹,⁹.0³,⁷]tridecan-2-yl acetate
[(3as,6s,6as,9s,9ar,9br)-9-hydroxy-6-methyl-3-methylidene-2-oxo-octahydro-3ah-azuleno[4,5-b]furan-9a-yl]methyl acetate
4-{7-hydroxy-7-methyl-3-methylidene-2-oxo-3ah,4h,8h,8ah-cyclohepta[b]furan-6-yl}butan-2-yl acetate
(3r,3as,4r,7s,11as)-4-hydroxy-3,6,10-trimethyl-2-oxo-3h,3ah,4h,7h,8h,11h,11ah-cyclodeca[b]furan-7-yl acetate
6-(acetyloxy)-3-hydroxy-1,4,5-trimethoxyhexan-2-yl acetate
2-(3,4-dimethoxyphenyl)-3-methyl-5-[(1e)-prop-1-en-1-yl]-1-benzofuran
(1r,4r,7r,8s,12s)-1-hydroxy-7-(2-hydroxypropan-2-yl)-4-methyl-3,13-dioxatetracyclo[10.2.1.0²,¹⁰.0⁴,⁸]pentadec-2(10)-en-11-one
(1r,3s)-1-[(3as,7s,8as)-7-methyl-3-methylidene-2-oxo-3ah,4h,7h,8h,8ah-cyclohepta[b]furan-6-yl]-3-hydroxybutyl acetate
(1s)-1-[(3s,3ar,7s,8ar)-3,7-dimethyl-2-oxo-3h,3ah,4h,7h,8h,8ah-cyclohepta[b]furan-6-yl]-3-oxobutyl acetate
(3s,3ar,4as,7s,7as,8s,9ar)-3,4a,8-trimethyl-2,5-dioxo-octahydro-3h-azuleno[6,5-b]furan-7-yl acetate
3,4a,8-trimethyl-2,5-dioxo-octahydro-3h-azuleno[6,5-b]furan-7-yl acetate
[(3ar,4as,5s,7as,8s,9ar)-5-hydroxy-8-methyl-3-methylidene-2-oxo-octahydro-3ah-azuleno[6,5-b]furan-4a-yl]methyl acetate
[(2s)-2-[2-(tert-butoxy)-5-methoxy-4-methylphenyl]oxiran-2-yl]methyl acetate
(3ar,4s,7ar)-5-[(2s)-5-hydroxypentan-2-yl]-6-methyl-3-methylidene-2-oxo-3a,4,7,7a-tetrahydro-1-benzofuran-4-yl acetate
3-[(2r,12bs)-1h,2h,3h,4h,6h,7h,12h,12bh-indolo[2,3-a]quinolizin-2-yl]-5h-furan-2-one
(3r,3as,4s,10s,11ar)-3,6,10-trimethyl-2,9-dioxo-3h,3ah,4h,5h,8h,10h,11h,11ah-cyclodeca[b]furan-4-yl acetate
(4s,5s,9as)-4-hydroxy-6,6,9a-trimethyl-3-oxo-1h,4h,5h,5ah,7h,8h,9h-naphtho[1,2-c]furan-5-yl acetate
(2s,3s,3'ar,6'r)-6'-hydroperoxy-3',3',6'-trimethyl-1',3'a,4',5'-tetrahydro-2h-spiro[furan-3,2'-inden]-2-yl acetate
(3ar,4as,5s,7as,8s,9ar)-4a-(hydroxymethyl)-8-methyl-3-methylidene-2-oxo-octahydro-3ah-azuleno[6,5-b]furan-5-yl acetate
(3s,3as,7r,9s,11as)-7-hydroxy-3,10-dimethyl-6-methylidene-2-oxo-3h,3ah,4h,5h,7h,8h,9h,11ah-cyclodeca[b]furan-9-yl acetate
10'-hydroxy-1',2',5'-trimethyl-8'-oxaspiro[oxirane-2,12'-tricyclo[7.2.1.0²,⁷]dodecan]-5'-en-11'-yl acetate
(4r,5s,5as,9as)-4-hydroxy-6,6,9a-trimethyl-1-oxo-3h,4h,5h,5ah,7h,8h,9h-naphtho[1,2-c]furan-5-yl acetate
1-acetoxy-6α-hydroxy-4αh-1,10-secoeudesma-5(10),11(13)-dien-12,8β-olide
{"Ingredient_id": "HBIN002239","Ingredient_name": "1-acetoxy-6\u03b1-hydroxy-4\u03b1h-1,10-secoeudesma-5(10),11(13)-dien-12,8\u03b2-olide","Alias": "NA","Ingredient_formula": "C17H24O5","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "SMIT14126","TCMID_id": "236","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
1β-acetoxy-7-drimen-11α-ol-12,11-lactone
{"Ingredient_id": "HBIN002381","Ingredient_name": "1\u03b2-acetoxy-7-drimen-11\u03b1-ol-12,11-lactone","Alias": "NA","Ingredient_formula": "C17H24O5","Ingredient_Smile": "CC(=O)OC1CCC(C2C1(C3C(OC(=O)C3=CC2)O)C)(C)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "176","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
4-acetoxy-1β,5β-epoxy-10αh-xantha-11(13)-en-12,8β-olide
{"Ingredient_id": "HBIN010159","Ingredient_name": "4-acetoxy-1\u03b2,5\u03b2-epoxy-10\u03b1h-xantha-11(13)-en-12,8\u03b2-olide","Alias": "NA","Ingredient_formula": "C17H24O5","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "191","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
6-α-acetyl-4-o-oxobedfordiaicacid
{"Ingredient_id": "HBIN012196","Ingredient_name": "6-\u03b1-acetyl-4-o-oxobedfordiaicacid","Alias": "NA","Ingredient_formula": "C17H24O5","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "474","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
8α-acetoxy-1β-hydroxyeudesm-3-en-5α,6β,7α,11βh-12,6-olide
{"Ingredient_id": "HBIN013617","Ingredient_name": "8\u03b1-acetoxy-1\u03b2-hydroxyeudesm-3-en-5\u03b1,6\u03b2,7\u03b1,11\u03b2h-12,6-olide","Alias": "NA","Ingredient_formula": "C17H24O5","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "217","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
Bakkenolide-X
{"Ingredient_id": "HBIN017543","Ingredient_name": "Bakkenolide-X","Alias": "NA","Ingredient_formula": "C17H24O5","Ingredient_Smile": "CC1CCC(C2C1(CC3(C2O)C(=C)COC3=O)C)OC(=O)C","Ingredient_weight": "308.4 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "35683","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "10733601","DrugBank_id": "NA"}
(3r,4s)-4,12-dihydroxy-14-methoxy-3-methyl-3,4,5,6,7,8,9,10-octahydro-2-benzoxacyclododecin-1-one
16-methyl-15-oxa-1,11-diazapentacyclo[15.3.1.0⁴,¹².0⁵,¹⁰.0¹³,¹⁸]henicosa-4(12),5,7,9,13-pentaen-20-one
(15r,19r)-15-ethyl-1,11-diazapentacyclo[9.7.1.0²,⁷.0⁸,¹⁹.0¹⁵,¹⁹]nonadeca-2,4,6,8-tetraene-10,18-dione
1-{2-[(2r)-but-3-en-2-yl]-3,4,6-trihydroxy-5-methylphenyl}-2-methylpropan-2-yl acetate
(3s,3ar,4s,5ar,6r,9bs)-6-hydroxy-3,5a,9-trimethyl-2-oxo-3h,3ah,4h,5h,6h,7h,8h,9bh-naphtho[1,2-b]furan-4-yl acetate
(2s,3s,3'ar,6's)-6'-hydroperoxy-3',3',6'-trimethyl-1',3'a,4',5'-tetrahydro-2h-spiro[furan-3,2'-inden]-2-yl acetate
7,12-dihydroxy-14-methoxy-3-methyl-3,4,5,6,7,8,9,10-octahydro-2-benzoxacyclododecin-1-one
methyl (4s)-3,4-diformyl-4-hydroxy-4a,8,8-trimethyl-5,6,7,8a-tetrahydro-1h-naphthalene-1-carboxylate
(3s,5r)-5,12-dihydroxy-14-methoxy-3-methyl-3,4,5,6,7,8,9,10-octahydro-2-benzoxacyclododecin-1-one
(3r,3ar,5r,7s,11ar)-7-hydroxy-3,10-dimethyl-6-methylidene-2-oxo-3h,3ah,4h,5h,7h,8h,9h,11ah-cyclodeca[b]furan-5-yl acetate
(2s)-7-hydroxy-8-[(1e)-3-methylbut-1-en-1-yl]-2-phenyl-2,3-dihydro-1-benzopyran-4-one
(3s,7r,11as)-7-hydroxy-3,10-dimethyl-6-methylidene-2-oxo-3h,3ah,4h,5h,7h,8h,9h,11ah-cyclodeca[b]furan-5-yl acetate
12-ethyl-9-hydroxy-8,16-diazatetracyclo[10.6.1.0²,⁷.0¹⁶,¹⁹]nonadeca-1(19),2,4,6,8,17-hexaen-15-one
8,12-dimethyl-4-(4-methylpent-3-en-1-yl)-2-oxatricyclo[7.3.1.0⁵,¹³]trideca-1(12),3,5(13),6,8-pentaene-10,11-dione
(1r,2s,3r,7s,8s,9r)-8-hydroxy-5,5,8-trimethyl-10-oxo-11-oxatetracyclo[7.3.1.0¹,⁹.0³,⁷]tridecan-2-yl acetate
{5-hydroxy-8-methyl-3-methylidene-2-oxo-octahydro-3ah-azuleno[6,5-b]furan-4a-yl}methyl acetate
(1s,3s,4s,6r,9e,11s,14s)-4,9,14-trimethyl-13-oxo-5,12-dioxatricyclo[9.3.0.0⁴,⁶]tetradec-9-en-3-yl acetate
3,6,9a-trimethyl-2,9-dioxo-octahydro-3h-azuleno[4,5-b]furan-8-yl acetate
(3r,3as,4s,4as,8s,8ar,9ar)-8-hydroxy-3-methyl-decahydrospiro[naphtho[2,3-b]furan-4,3'-oxane]-2,6'-dione
(3r,3as,6s,6as,8r,9ar,9br)-3,6,9a-trimethyl-2,9-dioxo-octahydro-3h-azuleno[4,5-b]furan-8-yl acetate
(2r,4s)-4-[(3ar,7s,8as)-7-methyl-3-methylidene-2-oxo-3ah,4h,7h,8h,8ah-cyclohepta[b]furan-6-yl]-4-hydroxybutan-2-yl acetate
(3ar,4as,5r,7s,7as,8r,9ar)-5-hydroxy-4a,8-dimethyl-3-methylidene-2-oxo-octahydro-3ah-azuleno[6,5-b]furan-7-yl acetate
(3s,3as,4s,4ar,8s,8ar,9ar)-8-hydroxy-3-methyl-decahydrospiro[naphtho[2,3-b]furan-4,3'-oxane]-2,6'-dione
(1's,2s,2'r,7'r,9'r,10'r,11's)-10'-hydroxy-1',2',5'-trimethyl-8'-oxaspiro[oxirane-2,12'-tricyclo[7.2.1.0²,⁷]dodecan]-5'-en-11'-yl acetate
(1s,4r,5z,7r,8s,9s)-7,8-dihydroxy-6,10,10-trimethyl-2-methylidene-3-oxobicyclo[7.2.0]undec-5-en-4-yl acetate
(1s,3r)-1-[(3ar,7s,8as)-7-methyl-3-methylidene-2-oxo-3ah,4h,7h,8h,8ah-cyclohepta[b]furan-6-yl]-3-hydroxybutyl acetate
(1s,3r,4s,7s,11r)-8-(4-methylpentanoyl)-2,10-dioxatricyclo[5.3.1.0⁴,¹¹]undec-8-en-3-yl acetate
(4s)-4-[(3ar,4r,7ar)-4-hydroxy-6-methyl-3-methylidene-2-oxo-3a,4,7,7a-tetrahydro-1-benzofuran-5-yl]pentyl acetate
(2r)-4-[(3ar,7r,8ar)-7-hydroxy-7-methyl-3-methylidene-2-oxo-3ah,4h,8h,8ah-cyclohepta[b]furan-6-yl]butan-2-yl acetate
3,8,12-trimethyl-13-oxo-4,14-dioxatricyclo[9.3.0.0³,⁵]tetradec-8-en-7-yl acetate
9a-hydroxy-3,5a-dimethyl-9-methylidene-2-oxo-octahydronaphtho[1,2-b]furan-6-yl acetate
6-(acetyloxy)-4-hydroxy-1,3,5-trimethoxyhexan-2-yl acetate
9b-hydroxy-6,6,9a-trimethyl-3-oxo-1h,5h,5ah,7h,8h,9h-naphtho[1,2-c]furan-5-yl acetate
{6-hydroxy-5a-methyl-3-methylidene-2-oxo-octahydro-3ah-naphtho[1,2-b]furan-9-yl}methyl acetate
(1r,3r)-1-[(3ar,7s,8as)-7-methyl-3-methylidene-2-oxo-3ah,4h,7h,8h,8ah-cyclohepta[b]furan-6-yl]-3-hydroxybutyl acetate
(3s,3as,5ar,6r,8s,9bs)-6-hydroxy-3,5a,9-trimethyl-2-oxo-3h,3ah,4h,5h,6h,7h,8h,9bh-naphtho[1,2-b]furan-8-yl acetate
(7r,8s)-4,8-dihydroxy-3,8-dimethyl-7-[(2e,4s)-4-methylhex-2-en-2-yl]-5h,7h-pyrano[3,2-c]pyran-2-one
5-hydroxy-3,5,8-trimethyl-2-oxo-3h,3ah,4h,6h,7h,8h,9h,9ah-azuleno[6,5-b]furan-7-yl acetate
4-[7-(acetyloxy)-2-hydroxy-6-methylheptan-2-yl]benzoic acid
3,6,10-trimethyl-2,9-dioxo-3h,3ah,4h,5h,8h,10h,11h,11ah-cyclodeca[b]furan-4-yl acetate
9a-hydroxy-3,4a,5-trimethyl-2-oxo-4h,5h,6h,7h,8h,8ah,9h-naphtho[2,3-b]furan-4-yl acetate
4,9,14-trimethyl-13-oxo-5,12-dioxatricyclo[9.3.0.0⁴,⁶]tetradec-9-en-3-yl acetate
(2r,4r)-4-[(3ar,7s,8as)-7-methyl-3-methylidene-2-oxo-3ah,4h,7h,8h,8ah-cyclohepta[b]furan-6-yl]-4-hydroxybutan-2-yl acetate
(1s,3s)-1-[(3ar,7s,8as)-7-methyl-3-methylidene-2-oxo-3ah,4h,7h,8h,8ah-cyclohepta[b]furan-6-yl]-3-hydroxybutyl acetate
(3as,4s,4ar,5s,7as,8r,9as)-4-hydroxy-4a,8-dimethyl-3-methylidene-2-oxo-octahydro-3ah-azuleno[6,5-b]furan-5-yl acetate
(3ar,4s,4ar,5s,7as,8r,9as)-4-hydroxy-4a,8-dimethyl-3-methylidene-2-oxo-octahydro-3ah-azuleno[6,5-b]furan-5-yl acetate
7-hydroxy-8-(3-methylbut-1-en-1-yl)-2-phenyl-2,3-dihydro-1-benzopyran-4-one
(8e)-4-methoxy-2-oxatricyclo[13.2.2.1³,⁷]icosa-1(17),3(20),4,6,8,15,18-heptaen-12-one
6-(3,7-dihydroxy-6,8-dimethyldeca-4,8-dien-2-yl)-4-hydroxypyran-2-one
n-[2-(2,2-dimethylchromen-6-yl)ethyl]pyridine-3-carboximidic acid
(1s,3s,7s,10r)-10-hydroxy-9,9-dimethyl-4-oxo-5-pentyl-2,8-dioxatricyclo[5.4.0.0¹,³]undec-5-ene-6-carbaldehyde
2-[(1r,2r,5s)-2-(acetyloxy)-5-methyl-4-(3-oxobutyl)cyclohept-3-en-1-yl]prop-2-enoic acid
(3r,3as,5as,6r,9ar,9bs)-9a-hydroxy-3,5a-dimethyl-9-methylidene-2-oxo-octahydronaphtho[1,2-b]furan-6-yl acetate
(3ar,4s,4as,5s,7as,8r,9as)-5-hydroxy-4a,8-dimethyl-3-methylidene-2-oxo-octahydro-3ah-azuleno[6,5-b]furan-4-yl acetate
ethyl 3-[(3as,8r,8ar)-8-hydroxy-6,8-dimethyl-3-methylidene-2-oxo-3ah,4h,5h,8ah-cyclohepta[b]furan-7-yl]propanoate
2-methoxy-4-{[5-(2-phenylethyl)furan-2-yl]methyl}phenol
4-[(3ar,7as)-4-hydroxy-6-methyl-3-methylidene-2-oxo-3a,4,7,7a-tetrahydro-1-benzofuran-5-yl]pentyl acetate
5-methyl-9-(3-methylbut-2-en-1-yl)-10h-phenazine-1-carboxylic acid
(2r,4r)-4-[(3as,7r,8as)-7-methyl-3-methylidene-2-oxo-3ah,4h,7h,8h,8ah-cyclohepta[b]furan-6-yl]-4-hydroxybutan-2-yl acetate
(3s)-3-[(3ar,6s,7r,8ar)-5,7-dimethyl-3-methylidene-2-oxo-3ah,6h,7h,8h,8ah-cyclohepta[b]furan-6-yl]-3-hydroxypropyl acetate
(2s,3r,4r,5s)-6-(acetyloxy)-4-hydroxy-1,3,5-trimethoxyhexan-2-yl acetate
4-hydroxy-6,6,9a-trimethyl-1-oxo-3h,4h,5h,5ah,7h,8h,9h-naphtho[1,2-c]furan-5-yl acetate
(3s,3as,5ar,6s,9r,9as,9bs)-9-hydroxy-3,5a,9-trimethyl-2-oxo-3h,3ah,4h,5h,6h,9ah,9bh-naphtho[1,2-b]furan-6-yl acetate
2,7-dihydroxy-3,6,9-trimethyl-4-(2-methylprop-1-en-1-yl)phenalen-1-one
(3s,3as,5as,6r,9ar,9bs)-9a-hydroxy-3,5a-dimethyl-9-methylidene-2-oxo-octahydronaphtho[1,2-b]furan-6-yl acetate
9a-hydroxy-3,4a,5-trimethyl-2-oxo-4h,5h,6h,7h,8h,8ah,9h-naphtho[2,3-b]furan-8-yl acetate
(3ar,4as,5s,7s,7as,8r,9as)-5-hydroxy-4a,8-dimethyl-3-methylidene-2-oxo-octahydro-3ah-azuleno[6,5-b]furan-7-yl acetate
(3s,3ar,4ar,5r,7s,7as,9ar)-5-hydroxy-3,5-dimethyl-8-methylidene-2-oxo-octahydro-3h-azuleno[6,5-b]furan-7-yl acetate
(6s,15s)-5,14-dihydroxy-1,4,10,13-tetraazatricyclo[13.3.0.0⁶,¹⁰]octadeca-4,13-diene-2,11-dione
C14H20N4O4 (308.14844800000003)